Dr. Andrea D. Jewell
Claim this profileUniversity of Kansas Cancer Center
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
16 reported clinical trials
38 drugs studied
About Andrea D. Jewell
Education:
- Earned an MD (Doctor of Medicine) from an unspecified institution.
Experience:
- Serves as Assistant Director, Administration and Education at the University of Kansas Cancer Center.
- Holds the Distinguished Kansas Masonic Professorship in Cancer Research.
Area of expertise
1Ovarian Cancer
Stage III
Stage II
Stage IV
2Fallopian Tube Cancer
Stage III
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Andrea D. Jewell is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Targeted Therapy + Atezolizumab
for Endometrial Cancer
This trial tests drugs that target cancer cells, sometimes combined with an immune-boosting drug called atezolizumab. It focuses on patients with endometrial cancer that has returned or is persistent. The drugs are chosen based on the genetic profile of the patient's tumor to improve effectiveness.
Recruiting1 award Phase 1 & 25 criteria
More about Andrea D. Jewell
Clinical Trial Related4 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Andrea D. Jewell has experience with
- Bevacizumab
- Paclitaxel
- Mirvetuximab Soravtansine
- Topotecan
- Olaparib
- Pembrolizumab
Breakdown of trials Andrea D. Jewell has run
Ovarian Cancer
Fallopian Tube Cancer
Adenocarcinoma
Serous Cystadenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrea D. Jewell specialize in?
Andrea D. Jewell focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage III patients, or patients who are Stage II.
Is Andrea D. Jewell currently recruiting for clinical trials?
Yes, Andrea D. Jewell is currently recruiting for 7 clinical trials in Westwood Kansas. If you're interested in participating, you should apply.
Are there any treatments that Andrea D. Jewell has studied deeply?
Yes, Andrea D. Jewell has studied treatments such as Bevacizumab, Paclitaxel, Mirvetuximab Soravtansine.
What is the best way to schedule an appointment with Andrea D. Jewell?
Apply for one of the trials that Andrea D. Jewell is conducting.
What is the office address of Andrea D. Jewell?
The office of Andrea D. Jewell is located at: University of Kansas Cancer Center, Westwood, Kansas 66205 United States. This is the address for their practice at the University of Kansas Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.